$2000 | Single User
$4000 | Site License
$6000 | Enterprise License

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018
[Report Updated: 14-08-2018]

Published by Global Markets Direct: 14 Aug 2018 | 217994 | In Stock
Related Topics: Healthcare , Heart Failure

Introduction

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.

Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver or abdomen, swollen feet and ankles and weight gain. There are two types of heart failure including systolic heart failure (left ventricle loses its ability to contract normally) and diastolic heart failure (left ventricle loses its ability to relax normally). The predisposing factors include high blood pressure, diabetes, sleep apnea, alcohol use and irregular heartbeats. Treatment includes surgery, vasodilator, beta blockers and diuretics.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Congestive Heart Failure (Heart Failure) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 13, 31, 21, 2, 61 and 14 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 21 and 4 molecules, respectively.

Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Congestive Heart Failure (Heart Failure) (Cardiovascular).

- The pipeline guide reviews pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Congestive Heart Failure (Heart Failure) (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Congestive Heart Failure (Heart Failure) (Cardiovascular)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Congestive Heart Failure (Heart Failure) (Cardiovascular).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
for Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018 [Report Updated: 14-08-2018]

  • Table of Contents

    Table of Contents 2

    Introduction 5

    Congestive Heart Failure (Heart Failure) - Overview 6

    Congestive Heart Failure (Heart Failure) - Therapeutics Development 7

    Congestive Heart Failure (Heart Failure) - Therapeutics Assessment 30

    Congestive Heart Failure (Heart Failure) - Companies Involved in Therapeutics Development 46

    Congestive Heart Failure (Heart Failure) - Drug Profiles 79

    Congestive Heart Failure (Heart Failure) - Dormant Projects 401

    Congestive Heart Failure (Heart Failure) - Discontinued Products 409

    Congestive Heart Failure (Heart Failure) - Product Development Milestones 411

    Appendix 423

Additional Details

Publisher

Global Markets Direct

Publisher Information

Reference

217994 | GMDHC10678IDB

Number of Pages

441

Report Format

PDF

Global Markets Direct Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017
Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2017SummaryGlobal Markets Direct's la...
15 Mar 2017 by Global Markets Direct USD $2,000 More Info
Global Congestive Heart Failure Partnering 2010 to 2017
The Global Congestive Heart Failure Partnering since 2010 report provides understanding and access t...
01 Feb 2017 by Current Partnering USD $1,495 More Info
Global Congestive Heart Failure Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Congestive Heart Failure Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016SummaryGlobalData's ...
31 Mar 2016 by Global Data USD $2,500 More Info
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2016SummaryGlobalData's ...
31 Mar 2016 by Global Data USD $2,500 More Info
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015
Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015SummaryGlobalData's ...
23 Dec 2015 by Global Data USD $2,500 More Info
Congestive Heart Failure - Pipeline Analysis
“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs ...
07 May 2015 by IQ4I USD $3,600 More Info
Congestive Heart Failure - Pipeline Analysis
“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs ...
07 May 2015 by IQ4I USD $3,600 More Info
Congestive Heart Failure - Pipeline Analysis
“Congestive Heart Failure (CHF) Pipeline Analysis” gives comprehensive insight on the various drugs ...
07 May 2015 by IQ4I USD $3,600 More Info

This report is published by Global Markets Direct

Download Free Report Summary PDF

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018 [Report Updated: 14-08-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)